Healthcare Discovery nasal spray brain aging Texas A&M extracellular vesicles 2026 showing vesicles reaching the hippocampus
| | |

A Nasal Spray That Reverses Brain Aging: The Texas A&M Breakthrough Reshaping Alzheimer’s Research

A two-dose nasal spray built from human neural stem cell-derived particles silenced the inflammation signals that drive cognitive decline, restored memory in aged mice, and is now being positioned for…

Luminous mitochondria undergoing quality control as NAD+ and MOTS-c signals support cellular aging
| |

The Mitochondrial Decade: Urolithin A, NAD+, MOTS-c, and the 2026 Science of Cellular Aging

In 2026, mitochondria have moved from a footnote in biology textbooks to the central organelle of aging research. From urolithin A’s mitophagy revolution to new NAD+ trials, MOTS-c, and the…

Healthcare Discovery klotho protein longevity cognitive aging 2026 showing kidney-brain signaling and memory resilience
| | |

The Klotho Protein: How a Single Longevity Hormone Is Reshaping Brain Aging Research in 2026

Discovered almost by accident in 1997 and named after the Greek fate that spins the thread of life, klotho is the longevity hormone that may connect kidney biology, cognitive aging,…

Healthcare Discovery longevity science reckoning coordination paradigm showing aging as interconnected biological systems
| |

Longevity Science Is Having a Reckoning: Why the Next Breakthrough May Not Be a Drug

Scientists at the 2nd World Congress on Targeting Longevity in Berlin delivered an uncomfortable verdict in April 2026: despite decades of discoveries, longevity science has stalled on clinical translation. The…

The Healthtech Intelligence Report | Healthcare Discovery
| | |

Mitochondrial Transplantation Enters Human Trials: How Moving Living Powerhouses Between Cells Is Rewriting Longevity Medicine

Mitochondrial transplantation, once a fringe idea, is now being tested in human clinical trials for heart failure, stroke, and age-related cellular decline. A new wave of 2026 research shows that…

Healthcare Discovery glycolytic metabolite PEP aging inflammation cGAS STING pathway showing metabolic brake on inflammaging
| | |

The Aging Body’s Hidden Brake: Scientists Discover a Glycolytic Metabolite That Suppresses Chronic Inflammation

A landmark 2026 study in Nature Aging reveals that phosphoenolpyruvate (PEP), a glycolytic metabolite, acts as a natural brake on the cGAS-STING inflammatory pathway. As PEP levels decline with age,…

Senolytic therapy targeting cellular senescence and zombie cells in aging tissue | Healthcare Discovery
| |

Senolytic CAR-T Cells: How Cancer Immunotherapy Is Being Reengineered to Clear Aging Cells

First-generation senolytics like dasatinib plus quercetin showed only subtle effects in human trials. A new generation of senolytic CAR-T cells borrows cancer immunotherapy and retrains it to hunt senescent cells….

Healthcare Discovery epigenetic reprogramming human trial ER-100 Life Biosciences showing retinal cells and controlled age reversal signals
| | |

The First Human Epigenetic Reprogramming Trial Has Begun: Inside ER-100 and What It Means for the Future of Aging Medicine

For the first time in history, a therapy designed to reverse the cellular age of human tissue is being tested in living patients. Here is what the science actually shows,…

Healthcare Discovery NAD+ brain aging sleep neurodegeneration research 2026 showing cellular fuel powering neurons and mitochondria
| | |

The NAD+ Renaissance: How a Cellular Fuel Molecule Is Rewriting the Science of Brain Aging, Sleep, and Neurodegeneration

A landmark Nature Aging expert review by 25 scientists, a Science Advances study showing NAD+ reverses Alzheimer’s memory deficits through RNA splicing, and the first human evidence that oral NAD+…